The China Mail - US authorizes first condom for use in anal sex

USD -
AED 3.672498
AFN 65.999546
ALL 83.886299
AMD 382.569343
ANG 1.789982
AOA 916.999667
ARS 1450.724895
AUD 1.535992
AWG 1.8025
AZN 1.703625
BAM 1.701894
BBD 2.013462
BDT 121.860805
BGN 1.698675
BHD 0.376969
BIF 2951
BMD 1
BND 1.306514
BOB 6.907654
BRL 5.340706
BSD 0.999682
BTN 88.718716
BWP 13.495075
BYN 3.407518
BYR 19600
BZD 2.010599
CAD 1.40972
CDF 2221.000107
CHF 0.8083
CLF 0.024025
CLP 942.260127
CNY 7.12675
CNH 7.124335
COP 3834.5
CRC 501.842642
CUC 1
CUP 26.5
CVE 96.374981
CZK 21.130974
DJF 177.719889
DKK 6.481435
DOP 64.297733
DZD 130.702957
EGP 47.350598
ERN 15
ETB 153.125026
EUR 0.868055
FJD 2.281097
FKP 0.766404
GBP 0.765345
GEL 2.714973
GGP 0.766404
GHS 10.924959
GIP 0.766404
GMD 73.496433
GNF 8691.000207
GTQ 7.661048
GYD 209.152772
HKD 7.774794
HNL 26.359887
HRK 6.537806
HTG 130.911876
HUF 335.451502
IDR 16695.1
ILS 3.253855
IMP 0.766404
INR 88.641051
IQD 1310
IRR 42112.439107
ISK 127.05977
JEP 0.766404
JMD 160.956848
JOD 0.709027
JPY 153.633017
KES 129.201234
KGS 87.449557
KHR 4027.000211
KMF 427.999878
KPW 900.033283
KRW 1447.48028
KWD 0.30713
KYD 0.83313
KZT 525.140102
LAK 21712.500514
LBP 89549.999727
LKR 304.599802
LRD 182.625016
LSL 17.379986
LTL 2.95274
LVL 0.60489
LYD 5.455014
MAD 9.301979
MDL 17.135125
MGA 4500.000656
MKD 53.533982
MMK 2099.044592
MNT 3585.031206
MOP 8.006805
MRU 38.249781
MUR 45.999702
MVR 15.404977
MWK 1736.000423
MXN 18.58737
MYR 4.18301
MZN 63.960022
NAD 17.380215
NGN 1440.729964
NIO 36.770288
NOK 10.170899
NPR 141.949154
NZD 1.7668
OMR 0.384495
PAB 0.999687
PEN 3.376505
PGK 4.216027
PHP 58.845981
PKR 280.85006
PLN 3.69242
PYG 7077.158694
QAR 3.640957
RON 4.414195
RSD 101.74198
RUB 81.125016
RWF 1450
SAR 3.750543
SBD 8.223823
SCR 13.740948
SDG 600.503506
SEK 9.536655
SGD 1.304925
SHP 0.750259
SLE 23.200677
SLL 20969.499529
SOS 571.507056
SRD 38.558019
STD 20697.981008
STN 21.45
SVC 8.747031
SYP 11056.895466
SZL 17.38022
THB 32.350333
TJS 9.257197
TMT 3.5
TND 2.960056
TOP 2.342104
TRY 42.11875
TTD 6.775354
TWD 30.898017
TZS 2459.806973
UAH 42.064759
UGX 3491.230589
UYU 39.758439
UZS 11987.497487
VES 227.27225
VND 26315
VUV 122.169446
WST 2.82328
XAF 570.814334
XAG 0.020533
XAU 0.000249
XCD 2.70255
XCG 1.801656
XDR 0.70875
XOF 570.495888
XPF 104.149691
YER 238.497406
ZAR 17.363401
ZMK 9001.204121
ZMW 22.392878
ZWL 321.999592
  • RYCEF

    0.0600

    15

    +0.4%

  • CMSC

    -0.0500

    23.75

    -0.21%

  • SCS

    -0.0500

    15.88

    -0.31%

  • GSK

    0.1100

    46.8

    +0.24%

  • NGG

    1.1600

    76.53

    +1.52%

  • RIO

    0.1850

    69.245

    +0.27%

  • RELX

    -1.4700

    43.11

    -3.41%

  • BTI

    0.5100

    54.39

    +0.94%

  • VOD

    0.0800

    11.35

    +0.7%

  • AZN

    2.7100

    83.86

    +3.23%

  • BCE

    0.8500

    23.24

    +3.66%

  • BCC

    -1.1810

    70.199

    -1.68%

  • RBGPF

    0.0000

    76

    0%

  • CMSD

    0.0100

    24.01

    +0.04%

  • JRI

    0.0050

    13.775

    +0.04%

  • BP

    0.1450

    35.825

    +0.4%

US authorizes first condom for use in anal sex
US authorizes first condom for use in anal sex

US authorizes first condom for use in anal sex

The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.

Text size:

Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.

Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.

Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.

"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.

The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.

"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.

The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.

The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.

Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.

Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.

Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.

"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.

In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.

D.Pan--ThChM